Integrin alpha-L (ITGAL or CD11a) Antibody - Western Blot Validated

Biological Background

Designed to help you characterize Integrin alpha-L, this antibody supports studies where protein context matters. Integrin alpha-L is an extracellular or receptor-linked component that coordinates matrix engagement with cytoskeletal remodeling. Its behavior can reflect changes in differentiation state, stress, or remodeling of cellular architecture.

In some datasets and protocols, it is referenced by the gene symbol ITGAL.

Use in the Laboratory

Matrix-interaction targets are often evaluated under changing substrate stiffness or ligand composition. Because regulation can be multi-layered, combining abundance and localization information can sharpen conclusions.

Depending on the model, researchers may ask whether signal shifts reflect altered abundance, compartment changes, or remodeling of associated complexes.

To keep datasets interpretable, labs often document:

• co-variation with cytoskeletal and scaffold partners
• remodeling after changes in substrate or mechanical stress
• effects of adhesion inhibitors or matrix composition

Version Notes

If your primary readout depends on denatured protein presentation, this option can streamline comparison across lanes and conditions. If your study compares multiple conditions, keep acquisition and processing settings stable to avoid confounding. Small differences in preparation can reshape apparent localization, so interpret results in context.

When interpreting Integrin alpha-L, consider whether changes track with compartment identity, cell density, or perturbation timing; these factors can influence apparent signal without implying a direct causal link.

Use the denaturing-format variant when your project demands Integrin alpha-L readouts that respect preparation constraints.